Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Boudreau

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Child Abuse & Neglect|February 21, 2018
Correlates of disclosure of sexual violence among Kenyan youthCourtney L Boudreau, Howard Kress, Roger W Rochat, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 10, 1999
New clothes for amyloid enhancing factor (AEF): silk as AEFR Kisilevsky, L Lemieux, L Boudreau, et al.
Molecular Therapy. Nucleic Acids|March 14, 2022
Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson's diseaseColleen S Stein, Jared M McLendon, Nathan H Witmer, et al.
Medsurg Nursing : Official Journal of the Academy of Medical-Surgical Nurses|December 31, 1997
Development of an ostomy competencyH A Clayton, L Boudreau, R Rodman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 27, 2025
Basic Science and PathogenesisGrace Rocco, Henry Lin, Kailey A Said, et al.
Experimental and Molecular Pathology|June 1, 1988
A reproducible model for the study of factor X kinetics in AA amyloidosisR Kisilevsky, A Giles, G Rae, et al.
Arthroscopy, Sports Medicine, and Rehabilitation|February 10, 2022
Customizing Functional Rehabilitation and Return to Sport in the Female Overhead AthleteStephanie L Boudreau, Laura L Mattes, Natalie A Lowenstein, et al.
Neurobiology of Disease|April 16, 2013
RNAi or overexpression: alternative therapies for Spinocerebellar Ataxia Type 1Megan S Keiser, James C Geoghegan, Ryan L Boudreau, et al.
Molecular Therapy. Nucleic Acids|April 8, 2015
Artificial miRNAs Targeting Mutant Huntingtin Show Preferential Silencing In Vitro and In VivoAlex Mas Monteys, Matthew J Wilson, Ryan L Boudreau, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 17, 2014
Nonallele specific silencing of ataxin-7 improves disease phenotypes in a mouse model of SCA7Pavitra S Ramachandran, Ryan L Boudreau, Kellie A Schaefer, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Child Abuse & Neglect|February 21, 2018
Correlates of disclosure of sexual violence among Kenyan youthCourtney L Boudreau, Howard Kress, Roger W Rochat, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 10, 1999
New clothes for amyloid enhancing factor (AEF): silk as AEFR Kisilevsky, L Lemieux, L Boudreau, et al.
Molecular Therapy. Nucleic Acids|March 14, 2022
Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson's diseaseColleen S Stein, Jared M McLendon, Nathan H Witmer, et al.
Medsurg Nursing : Official Journal of the Academy of Medical-Surgical Nurses|December 31, 1997
Development of an ostomy competencyH A Clayton, L Boudreau, R Rodman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 27, 2025
Basic Science and PathogenesisGrace Rocco, Henry Lin, Kailey A Said, et al.
Experimental and Molecular Pathology|June 1, 1988
A reproducible model for the study of factor X kinetics in AA amyloidosisR Kisilevsky, A Giles, G Rae, et al.
Arthroscopy, Sports Medicine, and Rehabilitation|February 10, 2022
Customizing Functional Rehabilitation and Return to Sport in the Female Overhead AthleteStephanie L Boudreau, Laura L Mattes, Natalie A Lowenstein, et al.
Neurobiology of Disease|April 16, 2013
RNAi or overexpression: alternative therapies for Spinocerebellar Ataxia Type 1Megan S Keiser, James C Geoghegan, Ryan L Boudreau, et al.
Molecular Therapy. Nucleic Acids|April 8, 2015
Artificial miRNAs Targeting Mutant Huntingtin Show Preferential Silencing In Vitro and In VivoAlex Mas Monteys, Matthew J Wilson, Ryan L Boudreau, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 17, 2014
Nonallele specific silencing of ataxin-7 improves disease phenotypes in a mouse model of SCA7Pavitra S Ramachandran, Ryan L Boudreau, Kellie A Schaefer, et al.
Pageof 8